Patent · US Active

Ophthalmic suspension composition

US11534395B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

BAUSCH & LOMB INCORPORATED · US

Inventors

Mohannad Shawer · Webster, US
Eric Phillips · Ontario, US
Martin J. Coffey · Tuggeranong, AU

Key dates

Filing date	Mar 23, 2020
Grant date	Dec 27, 2022
Priority date	—
Expiry date	Mar 23, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A suspension includes an ophthalmic active ingredient suspended in a formulation vehicle including a suspending agent and a non-ionic cellulose derivative. The ophthalmic active agent is present as particles having Dv90<5 μm and Dv50<1 μm. The suspension may be administered to a patient for treating an ophthalmic inflammatory condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.